OncoDiag
PrivateLast Round
Follow-on
Feb 5, 2025
Total Funding Raised
$4.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
OncoDiag is a genomics company that develops non-invasive diagnostic tests for the early detection and monitoring of bladder, colorectal, and prostate cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncoDiag Comparables
Compare OncoDiag with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VitaDX | 84% | |
| Nonagen Bioscience Corporation | 83% | |
| Nonacus | 80% |
OncoDiag Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on | Feb 5, 2025 | ||||
| Series A | Mar 15, 2021 |
OncoDiag Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Les Business Angels des Grandes Écoles | Seed |
| Normandie Participations | Series A |
| Paris Business Angels | Follow-on, Series A |
| Les Business Angels des Grandes Ecoles | Follow-on, Series A |
| Angels Santé | Follow-on, Seed, Series A |
| Normandie Participations | Follow-on, Series A |
| Bpifrance | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 85% MoM.
- Apr 17, 2026
Monthly visitors grew 70% MoM, reaching 1.5K.
OncoDiag Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about OncoDiag's valuation, stock price, and market status.
Is OncoDiag a public or private company?
OncoDiag is a private company.
What is the current stock price of OncoDiag?
OncoDiag is a private company with no public stock price. No recent secondary market data is available.
How much is OncoDiag worth (valuation)?
Valuation information for OncoDiag is not publicly available.
Can I buy OncoDiag stock?
OncoDiag shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was OncoDiag's last funding round?
OncoDiag's most recent funding round was Follow-on on February 5, 2025.
Who are the main investors in OncoDiag?
Key investors in OncoDiag include Les Business Angels des Grandes Écoles, Normandie Participations, Paris Business Angels, Les Business Angels des Grandes Ecoles, Angels Santé.
Will OncoDiag IPO soon?
No public IPO plans have been announced for OncoDiag.
How can I track OncoDiag secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OncoDiag's secondary market activity and sign up for updates.